chr15-29054039-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001353788.2(APBA2):c.155G>A(p.Arg52Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,613,814 control chromosomes in the GnomAD database, including 290 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.012 ( 16 hom., cov: 32)
Exomes 𝑓: 0.017 ( 274 hom. )
Consequence
APBA2
NM_001353788.2 missense
NM_001353788.2 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 1.24
Genes affected
APBA2 (HGNC:579): (amyloid beta precursor protein binding family A member 2) The protein encoded by this gene is a member of the X11 protein family. It is a neuronal adapter protein that interacts with the Alzheimer's disease amyloid precursor protein (APP). It stabilizes APP and inhibits production of proteolytic APP fragments including the A beta peptide that is deposited in the brains of Alzheimer's disease patients. This gene product is believed to be involved in signal transduction processes. It is also regarded as a putative vesicular trafficking protein in the brain that can form a complex with the potential to couple synaptic vesicle exocytosis to neuronal cell adhesion. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0037463903).
BP6
Variant 15-29054039-G-A is Benign according to our data. Variant chr15-29054039-G-A is described in ClinVar as [Benign]. Clinvar id is 3037758.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0125 (1898/152268) while in subpopulation NFE AF= 0.019 (1291/68024). AF 95% confidence interval is 0.0181. There are 16 homozygotes in gnomad4. There are 925 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 16 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APBA2 | NM_001353788.2 | c.155G>A | p.Arg52Gln | missense_variant | 4/15 | ENST00000683413.1 | NP_001340717.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1897AN: 152150Hom.: 16 Cov.: 32
GnomAD3 genomes
AF:
AC:
1897
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0135 AC: 3381AN: 251142Hom.: 37 AF XY: 0.0140 AC XY: 1905AN XY: 135804
GnomAD3 exomes
AF:
AC:
3381
AN:
251142
Hom.:
AF XY:
AC XY:
1905
AN XY:
135804
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0173 AC: 25265AN: 1461546Hom.: 274 Cov.: 32 AF XY: 0.0172 AC XY: 12481AN XY: 727046
GnomAD4 exome
AF:
AC:
25265
AN:
1461546
Hom.:
Cov.:
32
AF XY:
AC XY:
12481
AN XY:
727046
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0125 AC: 1898AN: 152268Hom.: 16 Cov.: 32 AF XY: 0.0124 AC XY: 925AN XY: 74444
GnomAD4 genome
AF:
AC:
1898
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
925
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
86
ALSPAC
AF:
AC:
70
ESP6500AA
AF:
AC:
15
ESP6500EA
AF:
AC:
158
ExAC
AF:
AC:
1746
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
APBA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;.;.;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;M;M;.;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;D;N;N;D;N
REVEL
Benign
Sift
Benign
D;D;D;T;D;D;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
B;B;.;.;B;.;.;.
Vest4
MPC
0.47
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at